.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Dose is stocked at 157 licensed dispensaries across Washington, Oklahoma, and 3 other states, 93 of them in Washington, with the deepest coverage in Seattle, Everett, Tacoma, Lynnwood, and Anacortes. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Dose concentrated 83.29% of its sales in Pre-Roll, where sales declined 15.91% year over year and 6.55% month over month, while Concentrates held 12.26% share with a 9.01% YoY increase but a 13.53% MoM dip. Smaller lines deteriorated sharply: Vapor Pens at 2.46% share fell 83.73% YoY and 44.40% MoM, and Flower at 1.99% share dropped 27.22% YoY and 12.55% MoM. With an overall brand sales contraction of 21.97% YoY and a 10.56% YoY decline in average price to $7.77, Dose’s category mix skews toward a declining Pre-Roll core rather than offsetting the weakness with growth pockets, implying volume reliance in a softening anchor and insufficient scale from secondary categories to stabilize topline.
The pattern implies a positioning tied to value Pre-Rolls — average price in Pre-Roll at $7.34 versus $10.46 in Concentrates — that pressures revenue when category velocity slips, and the current rank of 32 in Washington Pre-Rolls caps visibility. Concentrates’ 9.01% YoY growth is too small at 12.26% share to counter a 15.91% YoY decline in an 83.29% share lead category, and the 44.40% MoM fall in Vapor Pens removes any premium-price hedge relative to a 6.55% MoM contraction in Pre-Roll. The implication is a need to rebalance mix toward higher-price segments or deepen Pre-Roll differentiation, because current share-weighted declines and a lower price architecture constrain rank mobility and revenue resilience.
Competitive Landscape
Dose sits at rank 32 in WA Pre-Roll in August 2026, down 4 positions year over year from rank 28, and 8 spots below its three-month-ago position of 24, while remaining 10 ranks off its peak of 22 from February 2026; in contrast, Ooowee held rank 1 with no YoY movement and Lifted Cannabis Co climbed from rank 6 to rank 4. Compared with Phat Panda steady at rank 2 and Fire Bros. rising from rank 9 to rank 5, Dose’s 4-position YoY decline and 8-position slide since May 2026 indicate share is consolidating toward the top 5; the pattern implies Dose must reverse multi-quarter ranking loss to avoid slipping out of mid-tier relevance as incumbents widen the gap.
Notable Products
Skywalker OG Infused Pre-Roll (1g) delivered the standout move in August 2026 with a 128.5% month-over-month gain and a climb into rank 3, while Golden Strawberries Infused Pre-Roll (1g) fell 31.8% and slipped to rank 7. Blueberry Muffins Infused Pre-Roll (1g) rose 26.5% to hold rank 1, creating a top-three spread where ranks 1 and 3 are moving up while rank 2, God's Gift Infused Pre-Roll (1g), lacks a comparable growth signal. With all top-10 entries coming from Pre-Roll, the category concentration indicates Dose is consolidating around infused formats, implying a strategy to scale a few high-velocity SKUs rather than diversify across categories.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
